3'-End modification of the adenoviral VA1 gene affects its expression in human cells: Consequences for the design of chimeric VA1 RNA ribozymes

Antisense and Nucleic Acid Drug Development

Volumn 8, Issue 5, 1998, Pages 379-390

  Barcellini Couget, Sylvie ^a   Fenard, David ^a   Bertrand, Edouard ^b   Singer, Robert H ^b   Lefebvre, Jean Claude ^a   Doglio, Alain ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; RIBOZYME;

ADENOVIRUS; ARTICLE; CHIMERA; CLONING VECTOR; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION TERMINATION; VIRUS GENE; VIRUS REPLICATION;

EID: 0031795105     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1998.8.379     Document Type: Article

References (26)

1. AKUSJARVI, G., SVENSSON, C., and NYGARD, O. (1987). A mechanism by which adenovirus virus-associated RNAI controls translation in a transient expression assay. Mol. Cell. Biol. 7, 549-551.
2. BERTRAND, E., CASTANOTTO, D., ZHOU, C., CARBONELLE, C., LEE, N.S., GOOD, P., CHATTERJEE, S., GRANGE, T., PICTET, R., KOHN, D., ENGELKE, and D., ROSSI, J.J. (1997). The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA 3, 75-88.
3. BERTRAND, E., and ROSSI, J.J. (1996). Anti-HIV therapeutic hammerhead ribozymes: Targeting strategies and optimisation of intracellular function. Nucleic Acids Mol. Biol. 10, 301-313.
4. CAGNON, L., CUCCHIARINI, M., LEFEBVRE, J.C., and DOGLIO, A. (1995). Protection of a T-cell line from human immunodeficiency virus replication by the stable expression of a short antisense RNA sequence carried by a shuttle RNA molecule. J. AIDS 9, 349-385.
5. CAMPBELL, F.E., and SETZER, D.R. (1992). Transcription termination by RNA polymerase III: Uncoupling of polymerase release from termination signal recognition. Mol. Cel. Biol. 12, 2260-2272.
6. COTTEN, M., and BIRNSTIEL, M.L. (1989). Ribozyme mediated destruction of RNA in vivo. EMBO J. 8, 3861-3866.
7. GALLI, G., HOFSTETTER, H., and BIRNSTIEL, M.L. (1981). Two conserved blocks within eukaryotic tRNA genes are major promoter elements. Nature 294, 626-631.
8. GEIDUSCHEK, P.E. (1988). Transcription by RNA polymerase III. Annu. Rev. Biochem. 57, 873-914.
9. GHADGE, G.D., MALHOTRA, P., FURTADO, M.R., DHAR, R., and THIMMAPAYA, B. (1994). In vitro analysis of virus-associated RNA I (VA1 RNA): Inhibition of the double-stranded RNA-activated protein kinase PKR by VA1 RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain. J. Virol. 68, 4137-4151.
10. GOODRICH, J.A., and TJIAN, R. (1994). TBP-TAF complexes: Selectivity factors for eukaryotic transcription. Curr. Opin. Cell Biol. 6, 403-409.
11. HASELOFF, J., and GERLACH, W.L. (1988). Simple RNA enzymes with new and specific endoribonuclease activities. Nature 334, 585-591.
12. HORMES, R., HOMANN, M., OELZE, I., TABLER, M., MARSHALL, P., ECKSTEIN, F., and SCZAKIEL, G. (1997). The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells. Nucleic Acids Res 21, 2809-2814.
13. JENNINGS, P.A., and MOLLOY, P.L. (1987). Inhibition of SV40 replicon function by engineered antisense RNA transcribed by RNA polymerase III. EMBO J. 6, 3043-3047.
14. MA, Y., and MATHEWS, M.B. (1996). Secondary and tertiary structure in the central domain of adenovirus type 2 VA RNAI. RNA 2, 937-955.
15. MARAIA, R.J., KENAN, DJ., and KENE, J.D. (1994). Eucaryotic transcription termination factor La mediates transcript release and facilitates reinitiation by RNA polymerase III. Mol. Cell. Biol. 14, 2147-2158.
16. MARSCHALL, P., THOMSON, J.B., and ECKSTEIN, F. (1994). Inhibition of gene expression with ribozymes. Cell. Mol. Neurobiol. 14, 523-538.
17. MATHEWS, M.B., and SHENK, T. (1991). Adenovirus-associated RNA and translation control. J. Virol. 65, 5657-5662.
18. MELLITS, K.H., KOSTURA, M., and MATHEWS, M.B. (1990). Interaction of adenovirus VA RNAI with the protein kinase DAI: Non-equivalence of binding and function. Cell 61, 843-852.
19. PRISLEI, S., BUONOMO, S.B.C., MICHIENZI, A., and BOZZONI, I. (1997). Use of the VA1 small RNA as a carrier for cytoplasmic delivery of ribozymes. RNA 3, 677-687.
20. RAHMAN, A., MALHOTRA, P., DHAR, R., KEWALRAMANI, T., and THIMMAPAYA, B. (1995). Effect of single-base substitution in the central domain of virus-associated RNA I on its function. J. Virol. 69, 4299-1307.
21. SULLENGER, B.A., and CECH, T.R. (1993). Tethering ribozymes to a retroviral packaging signals for destruction of viral RNA. Science 262, 1566-1569.
22. SYMONS, R.H. (1994). Ribozymes. Curr. Opin. Struct. Biol. 4, 322-330.
23. THIMMAPPAYA, B., WEINBERGER, C., SCHNEIDER, R.J., and SHENK, T. (1982). Adenovinis VA1 RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31, 543-551.
24. THOMPSON, J.B., AYERS, D.F., MALMSTROM, T.A., McKENZIE, T.L., GANOUSIS, L., CHOWRIRA, B.M., and STINCHCOMB, D.T. (1995). Improved accumulation and activity of ribozymes expressed from a tRNA-based polymerase III promoter. Nucleic Acids Res. 23, 2259-2268.
25. YU, M., POESCHLA, E., and WONG-STAAL, F. (1994). Progress towards gene therapy for HIV infection. Gene Ther. 1, 13-26.
26. ZUKER, M., and STIEGER, P. (1981). Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res. 9, 133-148.